SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : MOON TRADER

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scotty who wrote (624)5/12/2002 5:06:53 AM
From: SnowShredder  Read Replies (1) of 808
 
Hi Scotty,

If they could come up with that test that would be great...maybe someone day they'll use a protein or DNA chip to do a scan to compare your samples with a standardized database.

I thought the recent Nature Medicine paper was interesting(the Nature journal family is an excellent group of journals...very well respected)...

ragingbull.lycos.com

Especially the part @ the end...

<"For example, radiotherapy can be used to destroy a primary tumor, but combined treatment with angiostatin has been shown to suppress metastases.">

I wonder if they got this info from the trial data or if it is from some preclinical work. Angiostatin used this way sounds very promising for ENMD...and I was looking for endostatin continuous infusion data to be interesting...not angiostatin...lol.

My thoughts are if their science sucks & they are going to run out of money...then why did the institutions as a whole acquire over a million shares more than they unloaded...

nasdaq.com

Also why does Fidelity own a >$9 million stake(as of 12/31/2001), and why did Orbimed Advisors, Fortis & HBK establish million dollar positions @ the end of last year or earlier this year. Not to mention Credit Suisse First Boston, and Goldman Sachs spent a few hundred K on ENMD at the end of last year too. That's a lot of money invested in a company that is going to run out of money(I doubt it was a technical buy, as the whole sector has been slammed, I doubt is was because they have a oodles of cash, as we know they don't, so what do they know that would provoke them to buy...cuz if the company goes under, some heads could roll). And to think that the short position increased?

nasdaq.com`&selected=ENMD&FormType=Institutional

Someone is going to lose...hope it's not me... as I established a long call option/leap position. I dream of a moon shot, but I'll be happy with breaking even. Oh no, I think I'm starting to sound like an emotionally attached long who gets blinded with hope...lol. With that being said, I think I'll re-evaluate things after the ASCO data is released. >gg<

Best of luck,

SS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext